160 related articles for article (PubMed ID: 23498384)
1. Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment.
Palmer BW; Ryan KA; Kim HM; Karlawish JH; Appelbaum PS; Kim SY
Am J Geriatr Psychiatry; 2013 Apr; 21(4):373-81. PubMed ID: 23498384
[TBL] [Abstract][Full Text] [Related]
2. Preservation of the capacity to appoint a proxy decision maker: implications for dementia research.
Kim SY; Karlawish JH; Kim HM; Wall IF; Bozoki AC; Appelbaum PS
Arch Gen Psychiatry; 2011 Feb; 68(2):214-20. PubMed ID: 21300949
[TBL] [Abstract][Full Text] [Related]
3. Variability of judgments of capacity: experience of capacity evaluators in a study of research consent capacity.
Kim SY; Appelbaum PS; Kim HM; Wall IF; Bourgeois JA; Frankel B; Hails KC; Rundell JR; Seibel KM; Karlawish JH
Psychosomatics; 2011; 52(4):346-53. PubMed ID: 21777717
[TBL] [Abstract][Full Text] [Related]
4. A memory and organizational aid improves Alzheimer disease research consent capacity: results of a randomized, controlled trial.
Rubright J; Sankar P; Casarett DJ; Gur R; Xie SX; Karlawish J
Am J Geriatr Psychiatry; 2010 Dec; 18(12):1124-32. PubMed ID: 20808101
[TBL] [Abstract][Full Text] [Related]
5. Cognitive models that predict physician judgments of capacity to consent in mild Alzheimer's disease.
Marson DC; Hawkins L; McInturff B; Harrell LE
J Am Geriatr Soc; 1997 Apr; 45(4):458-64. PubMed ID: 9100715
[TBL] [Abstract][Full Text] [Related]
6. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.
Palmer BW; Dunn LB; Appelbaum PS; Mudaliar S; Thal L; Henry R; Golshan S; Jeste DV
Arch Gen Psychiatry; 2005 Jul; 62(7):726-33. PubMed ID: 15997013
[TBL] [Abstract][Full Text] [Related]
7. Capacity to make treatment decisions in Chinese older persons with very mild dementia and mild Alzheimer disease.
Lui VW; Lam LC; Luk DN; Wong LH; Tam CW; Chiu HF; Appelbaum PS
Am J Geriatr Psychiatry; 2009 May; 17(5):428-36. PubMed ID: 19390300
[TBL] [Abstract][Full Text] [Related]
8. Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials.
Karlawish J; Kim SY; Knopman D; van Dyck CH; James BD; Marson D
Am J Geriatr Psychiatry; 2008 Jul; 16(7):568-74. PubMed ID: 18556397
[TBL] [Abstract][Full Text] [Related]
9. Qualitative analysis of the capacity to consent to treatment in patients with a chronic neurodegenerative disease: Alzheimer's disease / Analisi qualitativa sulla capacità a prestare consenso al trattamento in pazienti con malattie cronico degenerative neuropsicoorganiche: Demenza di Alzheimer.
Carabellese F; Felthous AR; La Tegola D; Piazzolla G; Distaso S; Logroscino G; Leo A; Ventriglio A; Catanesi R
Int J Soc Psychiatry; 2018 Feb; 64(1):26-36. PubMed ID: 29183264
[TBL] [Abstract][Full Text] [Related]
10. The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment.
Karlawish J; Kim SY; Knopman D; van Dyck CH; James BD; Marson D
Am J Geriatr Psychiatry; 2008 Mar; 16(3):240-7. PubMed ID: 18310554
[TBL] [Abstract][Full Text] [Related]
11. Cognitive models of physicians' legal standard and personal judgments of competency in patients with Alzheimer's disease.
Earnst KS; Marson DC; Harrell LE
J Am Geriatr Soc; 2000 Aug; 48(8):919-27. PubMed ID: 10968295
[TBL] [Abstract][Full Text] [Related]
12. The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment.
Karlawish JH; Casarett DJ; James BD; Xie SX; Kim SY
Neurology; 2005 May; 64(9):1514-9. PubMed ID: 15883310
[TBL] [Abstract][Full Text] [Related]
13. Capacity to provide informed consent among adults with bipolar disorder.
Klein CC; Jolson MB; Lazarus M; Masterson B; Blom TJ; Adler CM; DelBello MP; Strakowski SM
J Affect Disord; 2019 Jan; 242():1-4. PubMed ID: 30153563
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the capacity to appoint a healthcare proxy.
Moye J; Sabatino CP; Weintraub Brendel R
Am J Geriatr Psychiatry; 2013 Apr; 21(4):326-36. PubMed ID: 23498379
[TBL] [Abstract][Full Text] [Related]
15. Surrogate consent for dementia research: a national survey of older Americans.
Kim SY; Kim HM; Langa KM; Karlawish JH; Knopman DS; Appelbaum PS
Neurology; 2009 Jan; 72(2):149-55. PubMed ID: 19139366
[TBL] [Abstract][Full Text] [Related]
16. Toward a neurologic model of competency: Cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards.
Marson DC; Chatterjee A; Ingram KK; Harrell LE
Neurology; 1996 Mar; 46(3):666-72. PubMed ID: 8618664
[TBL] [Abstract][Full Text] [Related]
17. Assessing capacity to consent to treatment with cholinesterase inhibitors in dementia using a specific and standardized version of the MacArthur Competence Assessment Tool (MacCAT-T).
Mueller T; Haberstroh J; Knebel M; Oswald F; Kaspar R; Kemper CJ; Halder-Sinn P; Schroeder J; Pantel J
Int Psychogeriatr; 2017 Feb; 29(2):333-343. PubMed ID: 27825402
[TBL] [Abstract][Full Text] [Related]
18. Consistency of physician judgments of capacity to consent in mild Alzheimer's disease.
Marson DC; McInturff B; Hawkins L; Bartolucci A; Harrell LE
J Am Geriatr Soc; 1997 Apr; 45(4):453-7. PubMed ID: 9100714
[TBL] [Abstract][Full Text] [Related]
19. Comprehension of written texts for the assessment of clinical competence and decision making in people with mild to moderate Alzheimer disease.
Moro V; Valbusa V; Corsi N; Bonazzi A; Condoleo MT; Broggio E; Gambina G
Neurol Sci; 2020 May; 41(5):1225-1231. PubMed ID: 31901122
[TBL] [Abstract][Full Text] [Related]
20. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research.
Kim SY; Caine ED; Currier GW; Leibovici A; Ryan JM
Am J Psychiatry; 2001 May; 158(5):712-7. PubMed ID: 11329391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
